Citigroup’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.32K | Sell |
7,444
-68,393
| -90% | -$21.3K | ﹤0.01% | 4608 |
|
2025
Q1 | $37.1K | Sell |
75,837
-4,008
| -5% | -$1.96K | ﹤0.01% | 4191 |
|
2024
Q4 | $68.4K | Buy |
79,845
+10,178
| +15% | +$8.71K | ﹤0.01% | 4144 |
|
2024
Q3 | $592K | Buy |
69,667
+48,488
| +229% | +$412K | ﹤0.01% | 2889 |
|
2024
Q2 | $98.9K | Sell |
21,179
-97,625
| -82% | -$456K | ﹤0.01% | 3493 |
|
2024
Q1 | $808K | Sell |
118,804
-101,122
| -46% | -$688K | ﹤0.01% | 2517 |
|
2023
Q4 | $737K | Buy |
219,926
+153,950
| +233% | +$516K | ﹤0.01% | 2406 |
|
2023
Q3 | $164K | Buy |
+65,976
| New | +$164K | ﹤0.01% | 3074 |
|
2023
Q2 | – | Sell |
-353,138
| Closed | -$286K | – | 4791 |
|
2023
Q1 | $286K | Buy |
353,138
+352,845
| +120,425% | +$286K | ﹤0.01% | 2913 |
|
2022
Q4 | $223 | Sell |
293
-101,652
| -100% | -$77.4K | ﹤0.01% | 4788 |
|
2022
Q3 | $95K | Buy |
101,945
+92,868
| +1,023% | +$86.5K | ﹤0.01% | 3410 |
|
2022
Q2 | $9K | Buy |
9,077
+6,276
| +224% | +$6.22K | ﹤0.01% | 4646 |
|
2022
Q1 | $6K | Sell |
2,801
-2,702
| -49% | -$5.79K | ﹤0.01% | 4925 |
|
2021
Q4 | $49K | Buy |
5,503
+1,821
| +49% | +$16.2K | ﹤0.01% | 4302 |
|
2021
Q3 | $61K | Buy |
3,682
+585
| +19% | +$9.69K | ﹤0.01% | 3891 |
|
2021
Q2 | $64K | Buy |
3,097
+1,081
| +54% | +$22.3K | ﹤0.01% | 4027 |
|
2021
Q1 | $38K | Sell |
2,016
-1,820
| -47% | -$34.3K | ﹤0.01% | 4189 |
|
2020
Q4 | $85K | Buy |
3,836
+2,047
| +114% | +$45.4K | ﹤0.01% | 3773 |
|
2020
Q3 | $37K | Sell |
1,789
-139,848
| -99% | -$2.89M | ﹤0.01% | 3625 |
|
2020
Q2 | $5.12M | Buy |
141,637
+137,774
| +3,567% | +$4.98M | ﹤0.01% | 1077 |
|
2020
Q1 | $126K | Buy |
3,863
+2,541
| +192% | +$82.9K | ﹤0.01% | 3149 |
|
2019
Q4 | $36K | Buy |
1,322
+1,233
| +1,385% | +$33.6K | ﹤0.01% | 4186 |
|
2019
Q3 | $1K | Buy |
+89
| New | +$1K | ﹤0.01% | 5005 |
|